secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001140361-25-012621
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharma appoints Sarbani Chaudhuri as Chief Commercial & Medical Affairs Officer
--------------------------------------------------------------------------------

- Annual base salary of $525,000 with a target bonus of 45% of salary.
- Equity grant of ~$2,500,000 (50% options, 50% RSUs) vesting over three years.
- One-third of RSUs/options vest at first anniversary; remainder over two years quarterly.
- Sign-on bonus of $100,000 payable 30 days after start date, contingent on employment.
- Severance of 9 months salary plus COBRA; 12 months salary/bonus/COBRA on qualifying change-in-control termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036125012621/0001140361-25-012621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036125012621/ef20047021_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-012621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer